STI
18
11
TRIP
49
2
EBAY
53
3
AKAM
64
2
ALLE
44
3
THC
47
2
CHRW
82
3
WYNN
50
2
EMR
64
5
VZ
35
-2
URI
46
3
OI
47
-11
EXPD
51
16
AIG
77
2
MRK
63
3
PSX
37
2
AME
72
6
DG
74
2
EFX
54
2
JPM
70
3
STI
18
11
TRIP
49
2
EBAY
53
3
AKAM
64
2
ALLE
44
3
THC
47
2
CHRW
82
3
WYNN
50
2
EMR
64
5
VZ
35
-2
URI
46
3
OI
47
-11
EXPD
51
16
AIG
77
2
MRK
63
3
PSX
37
2
AME
72
6
DG
74
2
EFX
54
2
JPM
70
3
Financhill
Back

NeuroPace, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
67

NPCE
NeuroPace, Inc.

Last Price:
$16.62
Seasonality Move:
34.44%

7 Day Trial

ALL ACCESS PASS

$ 7

NeuroPace, Inc. Stock Forecast

  • Over the next 52 weeks, NeuroPace, Inc. has on average historically risen by 108% based on the past 4 years of stock performance.
  • NeuroPace, Inc. has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is NeuroPace, Inc. Stock Undervalued?
    The current NeuroPace, Inc. [NPCE] share price is $16.59. The Score for NPCE is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • NPCE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will NeuroPace, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, NeuroPace, Inc. has on average historically risen by 108% based on the past 4 years of stock performance.

NeuroPace, Inc. Stock Rating

Buy
67
NeuroPace, Inc. (NPCE) is a Buy

Is NeuroPace, Inc. overpriced?

  • NeuroPace, Inc. has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

NeuroPace, Inc. Stock Price History

Is NPCE stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NPCE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
neuropace.com

52-Week Data

52-Week High:
18.98
52-Week Low:
7.56

Prediction Charts

Market Cap:
552.6M
Price in USD:
16.59
Volume:
593.4K
Beta:
1.85

Technical Analysis

SMA50:
13.39
SMA100:
11.47
SMA200:
11.59
52-Wk Change:
48.92%

Stock Predictions

  • Is NeuroPace, Inc. stock public?
    Yes, NeuroPace, Inc. is a publicly traded company.
  • What is the NeuroPace, Inc. stock quote today?
    The NeuroPace, Inc. stock price is 16.59 USD today.
  • How to buy NeuroPace, Inc. stock online?
    You can buy NeuroPace, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 15.72 16.02 16.13 15.65
Dec-3 16.08 16.66 16.81 15.83
Dec-4 16.50 16.97 17.09 16.14
Dec-5 16.79 16.40 17.22 16.26
Dec-8 16.41 16.43 16.52 16.12
Dec-9 16.46 16.27 16.81 16.04
Dec-10 16.74 16.78 16.94 16.25
Dec-11 16.66 16.48 16.83 16.00
Dec-12 16.48 16.19 16.61 16.16
Dec-15 16.39 15.92 16.39 15.83
Dec-16 16.00 15.88 16.20 15.61
Dec-17 15.99 15.62 16.17 15.42
Dec-18 15.93 15.74 16.26 15.65
Dec-19 15.76 16.59 16.87 15.76

NeuroPace, Inc. Earnings

NeuroPace, Inc. Earnings Report: Per Share NeuroPace, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

NeuroPace, Inc. Forecast Revenue Growth

NeuroPace, Inc. Stock Analysis: Historical quarterly revenues per share for NeuroPace, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.15 per share.

* NeuroPace, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.